MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 112 filers reported holding MIRUM PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,227,218 | +32.5% | 38,836 | +8.5% | 0.00% | – |
Q2 2023 | $926,198 | +60.0% | 35,802 | +48.6% | 0.00% | – |
Q1 2023 | $578,882 | +23.2% | 24,100 | 0.0% | 0.00% | – |
Q4 2022 | $469,950 | +8.5% | 24,100 | +17.0% | 0.00% | – |
Q3 2022 | $433,000 | +8.0% | 20,600 | 0.0% | 0.00% | – |
Q2 2022 | $401,000 | -11.7% | 20,600 | 0.0% | 0.00% | – |
Q1 2022 | $454,000 | +38.0% | 20,600 | 0.0% | 0.00% | – |
Q4 2021 | $329,000 | -1.2% | 20,600 | +23.4% | 0.00% | – |
Q3 2021 | $333,000 | +15.2% | 16,700 | 0.0% | 0.00% | – |
Q2 2021 | $289,000 | -2.0% | 16,700 | +12.1% | 0.00% | – |
Q1 2021 | $295,000 | +13.5% | 14,900 | 0.0% | 0.00% | – |
Q4 2020 | $260,000 | +0.8% | 14,900 | +11.2% | 0.00% | – |
Q3 2020 | $258,000 | -1.1% | 13,400 | 0.0% | 0.00% | – |
Q2 2020 | $261,000 | -97.7% | 13,400 | -98.8% | 0.00% | -100.0% |
Q3 2019 | $11,517,000 | – | 1,144,813 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 3,566,912 | $62,278,000 | 4.80% |
RiverVest Venture Management LLC | 1,921,118 | $33,543,000 | 3.68% |
Burrage Capital Management LLC | 161,628 | $2,822,000 | 2.15% |
AIGH Capital Management LLC | 274,583 | $4,794,000 | 1.95% |
NEA Management Company, LLC | 4,187,801 | $73,119,000 | 1.93% |
Novo Holdings A/S | 2,445,147 | $42,692,000 | 1.83% |
Sio Capital Management, LLC | 494,743 | $8,638,000 | 1.77% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,448,912 | $60,218,000 | 1.19% |
Rock Springs Capital Management LP | 1,496,525 | $26,129,000 | 0.55% |
Prosight Management, LP | 60,250 | $1,052,000 | 0.49% |